Patents by Inventor Hae-Soo Kwak

Hae-Soo Kwak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240270126
    Abstract: A multi-position seat configured to maximize usability thereof through various changes in the positions of a seat back and a seat cushion may include a height assembly configured to move a base frame mounted on a vehicle body, a slide assembly configured to move a seat cushion frame, which is positioned above the base frame and is connected to the base frame via a link mechanism, upwards and downwards by sliding action of the link mechanism in a forward and backward direction, a tilt assembly configured to move a rear end portion of the seat cushion frame upwards and downwards, and a seat back frame hingedly coupled to a rear end portion of the base frame to be reclined.
    Type: Application
    Filed: April 22, 2024
    Publication date: August 15, 2024
    Applicants: Hyundai Motor Company, Kia Corporation, Hyundai Transys,Inc., Daechang Seat Co., LTD-Dongtan
    Inventors: Eun Sue KIM, Seung Sik Han, Hong Heui Lee, Myung Hoe Kim, Jong Tak Lee, Hae Dong Kwak, Cheol Hwan Yoon, Jun Sik Hwang, In Sun Baek, Sin Chan Yang, Myung Soo Lee, Chan Ki Cho
  • Patent number: 12036905
    Abstract: A backboard assembly for a vehicular rear seat is disclosed. The backboard assembly includes an upper part and a lower part, which are made of a hard plastic material. The backboard assembly prevents the formation of a gap between the lower part and a luggage board, regardless of the operational mode of the rear seat. When a seat back is folded, the upper part, the lower part, and the luggage board are aligned in a horizontal direction, thereby allowing the space for passengers in the rear seat to be completely integrated with a luggage compartment.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: July 16, 2024
    Assignees: Hyundai Motor Company, Kia Corporation, Hyundai Transys Inc., Daechang Seat Co., LTD-Dongtan
    Inventors: Eun Sue Kim, Seung Sik Han, Hong Heui Lee, Myung Hoe Kim, Cheol Hwan Yoon, Hae Dong Kwak, Jun Sik Hwang, Jong Tak Lee, Sin Chan Yang, In Sun Baek, Myung Soo Lee, Chan Ki Cho
  • Publication number: 20210007367
    Abstract: The present invention provides a lactase-containing double microcapsule which includes; lactase provided as a core material; and a primary coating material and a secondary coating material, which are sequentially coated on the core material to be formulated, a method for preparing the lactase-containing double microcapsule, and a dairy product including the lactase-containing double microcapsule as a use of the lactase-containing double microcapsule.
    Type: Application
    Filed: September 20, 2016
    Publication date: January 14, 2021
    Inventors: Hae-Soo KWAK, Sung-Il AHN
  • Patent number: 8323714
    Abstract: Shown herein is the use of crosslinked beta-cyclodextrin as a trap for removing cholesterol. The crosslinked beta-cyclodextrin is prepared by crosslinking beta-cyclodextrin in the presence of a crosslinking agent. Treatment with the crosslinked beta-cyclodextrin results in cholesterol-depleted foods. After application to foods, the crosslinked beta-cyclodextrin which traps cholesterol therein can be readily regenerated with organic solvents. The crosslinked beta-cyclodextrin can be applied to almost all cholesterol-containing foods, such as dairy products, meat products, and egg products, with excellent cholesterol removal rates.
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: December 4, 2012
    Inventors: Hae-Soo Kwak, Song-Hee Kim, Jung Jwa Ahn
  • Publication number: 20110190487
    Abstract: Disclosed herein is the use of crosslinked beta-cyclodextrin as a trap for removing cholesterol. The crosslinked beta-cyclodextrin is prepared by crosslinking beta-cyclodextrin in the presence of a crosslinking agent. Treatment with the crosslinked beta-cyclodextrin results in cholesterol-depleted foods. After application to foods, the crosslinked beta-cyclodextrin which traps cholesterol therein can be readily regenerated with organic solvents. The crosslinked beta-cyclodextrin can be applied to almost all cholesterol-containing foods, such as dairy products, meat products, and egg products, with excellent cholesterol removal rates.
    Type: Application
    Filed: March 1, 2011
    Publication date: August 4, 2011
    Inventors: Hae-Soo Kwak, Song-Hee Kim, Jung Jwa Ahn
  • Patent number: 7919130
    Abstract: Shown herein is the use of crosslinked beta-cyclodextrin as a trap for removing cholesterol. The crosslinked beta-cyclodextrin is prepared by crosslinking beta-cyclodextrin in the presence of a crosslinking agent. Treatment with the crosslinked beta-cyclodextrin results in cholesterol-depleted foods. After application to foods, the crosslinked beta-cyclodextrin which traps cholesterol therein can be readily regenerated with organic solvents. The crosslinked beta-cyclodextrin can be applied to almost all cholesterol-containing foods, such as dairy products, meat products, and egg products, with excellent cholesterol removal rates.
    Type: Grant
    Filed: October 26, 2005
    Date of Patent: April 5, 2011
    Inventors: Hae-Soo Kwak, Song-Hee Kim, Jung Jwa Ahn
  • Publication number: 20070093447
    Abstract: Disclosed herein is the use of crosslinked beta-cyclodextrin as a trap for removing cholesterol. The crosslinked beta-cyclodextrin is prepared by crosslinking beta-cyclodextrin in the presence of a crosslinking agent. Treatment with the crosslinked beta-cyclodextrin results in cholesterol-depleted foods. After application to foods, the crosslinked beta-cyclodextrin which traps cholesterol therein can be readily regenerated with organic solvents. The crosslinked beta-cyclodextrin can be applied to almost all cholesterol-containing foods, such as dairy products, meat products, and egg products, with excellent cholesterol removal rates.
    Type: Application
    Filed: October 26, 2005
    Publication date: April 26, 2007
    Inventors: Hae-Soo Kwak, Song-Hee Kim, Jung-Jwa Ahn
  • Patent number: 7018820
    Abstract: Disclosed is a method of removing residual enzymes when microencapsulating enzymes, and more particularly, for inactivating enzymes remaining in an uncapsulated form during microencapsulation of enzymes by treating dispersion fluid of microcapsules containing enzymes with ozone, together with removal of microorganisms harmful to human beings, where the ozone treatment is conducted for 1–10 min with 1–10 ppm of ozone generated from a UV lamp in a range from 150 to 200 nm wavelength.
    Type: Grant
    Filed: July 17, 2002
    Date of Patent: March 28, 2006
    Inventors: Hae-Soo Kwak, Joon Bum Lee
  • Publication number: 20030148483
    Abstract: Disclosed is a method of removing residual enzymes when microencapsulating enzymes, and more particularly, for inactivating enzymes remaining in an uncapsulated form during microencapsulation of enzymes by treating dispersion fluid of microcapsules containing enzymes with ozone, together with removal of microorganisms harmful to human beings, where the ozone treatment is conducted for 1-10 min with 1-10 ppm of ozone generated from a UV lamp in a range from 150 to 200 nm wavelength.
    Type: Application
    Filed: July 17, 2002
    Publication date: August 7, 2003
    Inventors: Hae-Soo Kwak, Joon Bum Lee
  • Patent number: 6491955
    Abstract: A &bgr;-D-galactosidase which is encapsulated with fatty acid ester, does not exert its hydrolysis function in milk but hydrolyze lactose in the human body. Hence, the milk containing the encapsulated &bgr;-D-galactosidase, does not change in sweetness with storage and is digestible to the &bgr;-D-galactosidase-deficient people. In addition, the milk can maintain its characteristic taste without off-flavor by virtue of the excellent feature of fatty acid ester.
    Type: Grant
    Filed: May 4, 2000
    Date of Patent: December 10, 2002
    Assignee: Anigen Co., Ltd.
    Inventors: Hae-Soo Kwak, Mi-Ri Lim
  • Patent number: 6402997
    Abstract: Disclosed is a method for preparing a water soluble iron-containing microcapsule by use of fatty acid ester, which is advantageous in terms of shortened preparation process of emulsion and microcapsule, the use of tasteless and odorless fatty acid ester as emulsifier, and increased preparation yield of 95% or more while the microcapsule has the size of 2-5 &mgr;m. The method comprises preparing a mixture of a coating agent and iron by mixing polyglycerin stearate with ferric ammonium sulfate in the ratio of 5:1-25:1 and stirring at 500-1200×g for 30 seconds to 2 minutes, said polyglycerin stearate having been mixed with a predetermined amount of water and allowed to stand at 45-60° C. for 5-20 minutes, said polyglycerin stearate and ferric ammonium sulfate serving as the coating agent and iron, respectively; spraying said mixture to a dispersion of 0.01-0.1% surfactant in purified water of 5-10° C.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: June 11, 2002
    Inventors: Hae-Soo Kwak, Kyung-Mi Yang
  • Patent number: 6110517
    Abstract: There is disclosed a method for removing cholesterol from milk and cream at a high efficiency without deleteriously affecting the product quality. After homogenization, milk is added with .beta.-cyclodextrin at an amount of 0.5-5% (w/v). The milk is stirred at 4-30.degree. C. and at 200-2,000 rpm for 5-30 min, followed by centrifugation at 22-555.times.g for 5-30 min. Similarly, cream is added with .beta.-cyclodextrin at an amount of 1-20% (w/v) and then, treated by stirring at 20-60.degree. C. and at 400-4,000 rpm for 5-60 min and centrifuging at 222-444.times.g.
    Type: Grant
    Filed: July 29, 1998
    Date of Patent: August 29, 2000
    Assignee: Se Jong University
    Inventors: Hae Soo Kwak, Joung Jwa Ahn, Dong Kuk Lee